Literature DB >> 25318429

Myeloid cells' evasion of melanoma immunity.

Jun Wang1, Lieping Chen2.   

Abstract

An immune-suppressive role of myeloid-derived suppressor cells (MDSCs) in melanoma has long been speculated, whereas molecular mechanisms underlying this role are not well understood. Here, Chung and colleagues show that dendritic cell-associated, heparan sulfate proteoglycans-dependent integrin ligand (DC-HIL), a cell surface immune-modulatory molecule, is highly expressed on tumor-associated MDSCs. Genetic ablation or antibody blockade of DC-HIL delays the growth of transplantable B16 melanoma in syngeneic mice, which is accompanied by enhanced antitumor T-cell activities. These findings support a role for DC-HIL in immune evasion within the melanoma microenvironment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25318429      PMCID: PMC4455019          DOI: 10.1038/jid.2014.251

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans.

Authors:  S Shikano; M Bonkobara; P K Zukas; K Ariizumi
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

2.  DC-HIL is a negative regulator of T lymphocyte activation.

Authors:  Jin-Sung Chung; Kota Sato; Irene I Dougherty; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

3.  DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells.

Authors:  Mizuki Tomihari; Jin-Sung Chung; Hideo Akiyoshi; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

4.  nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts.

Authors:  M A Weterman; N Ajubi; I M van Dinter; W G Degen; G N van Muijen; D J Ruitter; H P Bloemers
Journal:  Int J Cancer       Date:  1995-01-03       Impact factor: 7.396

5.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

6.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Authors:  Julie R Brahmer; Scott S Tykodi; Laura Q M Chow; Wen-Jen Hwu; Suzanne L Topalian; Patrick Hwu; Charles G Drake; Luis H Camacho; John Kauh; Kunle Odunsi; Henry C Pitot; Omid Hamid; Shailender Bhatia; Renato Martins; Keith Eaton; Shuming Chen; Theresa M Salay; Suresh Alaparthy; Joseph F Grosso; Alan J Korman; Susan M Parker; Shruti Agrawal; Stacie M Goldberg; Drew M Pardoll; Ashok Gupta; Jon M Wigginton
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

7.  Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα.

Authors:  Pratima Sinha; Katherine H Parker; Lucas Horn; Suzanne Ostrand-Rosenberg
Journal:  Eur J Immunol       Date:  2012-08       Impact factor: 5.532

8.  The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses.

Authors:  Jin-Sung Chung; Makoto Bonkobara; Mizuki Tomihari; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

9.  Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation.

Authors:  Jin-Sung Chung; Irene Dougherty; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

10.  DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth.

Authors:  Jin-Sung Chung; Kyoichi Tamura; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  J Invest Dermatol       Date:  2014-06-17       Impact factor: 8.551

View more
  1 in total

Review 1.  Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.

Authors:  Arvindhan Nagarajan; Parmanand Malvi; Narendra Wajapeyee
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-24       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.